Form 4: Johnson & Johnson Director Weinberger Acquires Deferred Share Units

Mark A. Weinberger, a director at Johnson & Johnson, acquired 1,316 deferred share units under the company's Amended and Restated Deferred Fee Plan for Directors on April 24, 2025.

Summary

• On April 24, 2025, Mark A. Weinberger, a director of Johnson & Johnson, acquired 1,316 Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• These DSUs will be settled in cash upon the termination of Weinberger's directorship, with each DSU representing the fair market value of one share of Johnson & Johnson common stock on the settlement date.
• Following the transaction, Weinberger beneficially owns 10,737.364 derivative securities, which includes dividend equivalent rights accrued on the DSUs.
• The transaction was reported on April 28, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing reflects standard director compensation practices and insider alignment with company performance. There are no indications of negative events or concerns.

Positives

• The acquisition of Deferred Share Units aligns the director's interests with the long-term performance of the company.
• The Deferred Fee Plan for Directors allows for a flexible compensation structure.

Future Outlook

The Deferred Share Units will be settled in cash upon the termination of the Reporting Person's directorship.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's continued investment in the company's future.

Comparison to Industry Standards

• Deferred compensation plans are a common practice among large publicly traded companies like Johnson & Johnson to attract and retain qualified directors.
• Companies such as Pfizer (PFE) and Merck (MRK) also utilize similar deferred compensation strategies for their board members.
• The specific terms of these plans, such as the vesting schedule and settlement method, can vary based on company policy and industry benchmarks.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning director interests with company performance.
• The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Deferred Share Units, Director Compensation, Form 4, Johnson & Johnson, JNJ, Insider Trading, Beneficial Ownership, Weinberger